We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $504M → $0 (-$504M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
-$37.5M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$28.2M
3
TAL
TIG Advisors LLC
New York
-$27.1M
4
WIC
Water Island Capital
New York
-$26.3M
5
MF
Magnetar Financial
Illinois
-$23.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAM
1
Alpine Associates Management
Florida
– -$37.5M -1,790,400 Closed
Allianz Asset Management
2
Allianz Asset Management
Germany
– -$28.2M -1,350,000 Closed
TAL
3
TIG Advisors LLC
New York
– -$27.1M -1,294,759 Closed
WIC
4
Water Island Capital
New York
– -$26.3M -1,255,878 Closed
MF
5
Magnetar Financial
Illinois
– -$23.5M -1,122,841 Closed
BFA
6
BlackRock Fund Advisors
California
– -$23.1M -1,105,516 Closed
GLAM
7
Gardner Lewis Asset Management
Pennsylvania
– -$22.7M -1,084,858 Closed
AIC
8
AWM Investment Company
New York
– -$22.2M -1,062,498 Closed
AA
9
AQR Arbitrage
Connecticut
– -$19.7M -942,400 Closed
Vanguard Group
10
Vanguard Group
Pennsylvania
– -$19.6M -935,064 Closed
Fidelity Investments
11
Fidelity Investments
Massachusetts
– -$15.2M -725,715 Closed
DCM
12
DAFNA Capital Management
California
– -$15M -715,988 Closed
GCL
13
Glazer Capital LLC
New York
– -$15M -715,000 Closed
BBA
14
Baker Bros. Advisors
New York
– -$13.3M -637,597 Closed
Deutsche Bank
15
Deutsche Bank
Germany
– -$12.4M -591,057 Closed
BIT
16
BlackRock Institutional Trust
California
– -$11.3M -541,906 Closed
CS
17
Credit Suisse
Switzerland
– -$9.79M -467,964 Closed
GP
18
GLG Partners
United Kingdom
– -$9.36M -447,289 Closed
OAM
19
Oxford Asset Management
United Kingdom
– -$9.34M -446,618 Closed
CC
20
Coastland Capital
California
– -$9.28M -443,619 Closed
State Street
21
State Street
Massachusetts
– -$8.1M -387,390 Closed
SCM
22
Stevens Capital Management
Pennsylvania
– -$7.93M -379,030 Closed
COPPSERS
23
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$7.47M -357,240 Closed
GF
24
Gabelli Funds
New York
– -$5.84M -279,105 Closed
Northern Trust
25
Northern Trust
Illinois
– -$5.65M -270,149 Closed
1
2 3 4

VTAE Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2016, worth a combined $0 — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTAE and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $37.5M sold.

  • 0 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $0 of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2016 and 98 closed out, a net change of -98 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2016 was Alpine Associates Management, an estimated $37.5M sold.

Based on aggregated 13F filings for Q4 2016.